Trademark: 79149152
Status Date
Sunday, May 1, 2022
Registration Number
4774665
Registration Date
Tuesday, July 21, 2015
Filing Date
Tuesday, April 29, 2014
Published for Opposition
Tuesday, May 5, 2015
9 [ Scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; Laboratory apparatus and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes ]
5 [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
42 Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services [ and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] pharmaceutical research and development; Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
Jun 7, 2023
Limitation From The Ib Examined, No Action Is Needed
Mar 28, 2023
Partial Invalidation Processed By The Ib
Mar 27, 2023
Limitation Of Goods Received From Ib
Feb 22, 2023
Partial Invalidation Of Reg Ext Protection Sent To Ib
Feb 22, 2023
Invalidation Processed
Jan 1, 2023
Partial Invalidation Of Reg Ext Protection Created
May 1, 2022
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
May 1, 2022
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Apr 7, 2022
Case Assigned To Post Registration Paralegal
Feb 16, 2022
Case Assigned To Post Registration Paralegal
Jul 21, 2021
Teas Section 71 & 15 Received
Jul 21, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 4, 2016
Final Decision Transaction Processed By Ib
Dec 2, 2015
Final Disposition Notice Sent To Ib
Dec 2, 2015
Final Disposition Processed
Oct 21, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jul 21, 2015
Registered-Principal Register
May 5, 2015
Official Gazette Publication Confirmation E-Mailed
May 5, 2015
Published For Opposition
May 2, 2015
Notification Processed By Ib
Apr 15, 2015
Notification Of Possible Opposition Sent To Ib
Apr 15, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 15, 2015
Notification Of Notice Of Publication E-Mailed
Mar 27, 2015
Law Office Publication Review Completed
Mar 27, 2015
Assigned To Lie
Mar 9, 2015
Approved For Pub - Principal Register
Feb 27, 2015
Teas/Email Correspondence Entered
Feb 26, 2015
Correspondence Received In Law Office
Feb 26, 2015
Teas Response To Office Action Received
Oct 23, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 23, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 11, 2014
Refusal Processed By Ib
Aug 26, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Aug 26, 2014
Refusal Processed By Mpu
Aug 26, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Aug 25, 2014
Non-Final Action Written
Aug 25, 2014
Non-Final Action (Ib Refusal) Withdrawn For Review
Aug 22, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Aug 21, 2014
Non-Final Action Written
Aug 13, 2014
Assigned To Examiner
Aug 2, 2014
Application Filing Receipt Mailed
Jul 29, 2014
New Application Office Supplied Data Entered
Jul 19, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
